150 related articles for article (PubMed ID: 37013353)
1. A Case of Mediastinal Carcinosarcoma With Beta-HCG Production and KRAS Mutation.
Shaker N; Amadi CC; Welliver M; Otterson GA; Liebner DA; Shilo K
Int J Surg Pathol; 2023 Dec; 31(8):1598-1604. PubMed ID: 37013353
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic carcinosarcoma with the same KRAS gene mutation in both carcinomatous and sarcomatous components: molecular evidence for monoclonal origin of the tumour.
Bai Q; Zhang X; Zhu X; Wang L; Huang D; Cai X; Zhou X; Wang J; Sheng W
Histopathology; 2016 Sep; 69(3):393-405. PubMed ID: 27307095
[TBL] [Abstract][Full Text] [Related]
3. Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas.
Mirkovic J; Olkhov-Mitsel E; Amemiya Y; Al-Hussaini M; Nofech-Mozes S; Djordjevic B; Kupets R; Seth A; McCluggage WG
Histopathology; 2023 Jun; 82(7):978-990. PubMed ID: 36860193
[TBL] [Abstract][Full Text] [Related]
4. Intraductal carcinosarcoma with a heterologous mesenchymal component originating in intraductal papillary-mucinous carcinoma (IPMC) of the pancreas with both carcinoma and osteosarcoma cells arising from IPMC cells.
Okamura J; Sekine S; Nara S; Ojima H; Shimada K; Kanai Y; Hiraoka N
J Clin Pathol; 2010 Mar; 63(3):266-9. PubMed ID: 20203229
[TBL] [Abstract][Full Text] [Related]
5. Two Components of Variant Profiles in Primary Vaginal Carcinosarcoma via Next-Generation Sequencing and a Literature Review.
Kotoku R; Yanazume S; Kuroda T; Kobayashi Y; Kitazono I; Akahane T; Tanimoto A; Kobayashi H
Int J Surg Pathol; 2022 May; 30(3):288-294. PubMed ID: 34463147
[TBL] [Abstract][Full Text] [Related]
6. Molecular and expressional characterization of tumor heterogeneity in pulmonary carcinosarcoma.
Ohtaki Y; Kawabata-Iwakawa R; Nobusawa S; Goto Y; Shimizu K; Yajima T; Nakazawa S; Kawatani N; Yoshida Y; Sano T; Shirabe K
Mol Carcinog; 2022 Oct; 61(10):924-932. PubMed ID: 35848137
[TBL] [Abstract][Full Text] [Related]
7. KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice.
Tang FH; Hsieh TH; Hsu CY; Lin HY; Long CY; Cheng KH; Tsai EM
Int J Cancer; 2017 Apr; 140(8):1860-1869. PubMed ID: 28032649
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing analysis identifies genomic alterations in pathological morphologies: A case of pulmonary carcinosarcoma harboring EGFR mutations.
Koba H; Kimura H; Nishikawa S; Sone T; Abo M; Hara J; Hosomichi K; Tajima A; Kasahara K
Lung Cancer; 2018 Aug; 122():146-150. PubMed ID: 30032823
[TBL] [Abstract][Full Text] [Related]
9. The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene.
Toyokawa G; Takenoyama M; Taguchi K; Arakaki K; Inamasu E; Toyozawa R; Kojo M; Shiraishi Y; Morodomi Y; Takenaka T; Hirai F; Yamaguchi M; Seto T; Leone A; Graziano P; Ichinose Y
Lung Cancer; 2013 Sep; 81(3):491-494. PubMed ID: 23891513
[TBL] [Abstract][Full Text] [Related]
10. Ovarian Carcinosarcoma and Concurrent Serous Tubal Intraepithelial Carcinoma With Next-Generation Sequencing Suggesting an Origin From the Fallopian Tube.
See SHC; Behdad A; Maniar KP; Blanco LZ
Int J Surg Pathol; 2019 Aug; 27(5):574-579. PubMed ID: 30913944
[No Abstract] [Full Text] [Related]
11. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a novel uterine carcinosarcoma cell line, TU-ECS-1, with mutations of TP53 and KRAS.
Chiba Y; Sato S; Itamochi H; Suga Y; Fukagawa T; Oumi N; Oishi T; Harada T; Sugai T; Sugiyama T
Hum Cell; 2017 Apr; 30(2):140-148. PubMed ID: 27889902
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin.
Growdon WB; Roussel BN; Scialabba VL; Foster R; Dias-Santagata D; Iafrate AJ; Ellisen LW; Tambouret RH; Rueda BR; Borger DR
Gynecol Oncol; 2011 Apr; 121(1):212-7. PubMed ID: 21168197
[TBL] [Abstract][Full Text] [Related]
14. [Carcinosarcomas of the uterus: molecular-genetic and morphological features].
Levitskaia NV; Pozharisskiĭ KM; Vostriukhina OA; Alekseeva LN; Nemtsova MV; Matrosova IV; Kharitonova TV; Poddubnaia IV
Arkh Patol; 2012; 74(1):7-11. PubMed ID: 22712296
[TBL] [Abstract][Full Text] [Related]
15. Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.
Lococo F; Gandolfi G; Rossi G; Pinto C; Rapicetta C; Cavazza A; Cesario A; Galeone C; Paci M; Ciarrocchi A
J Thorac Oncol; 2016 Aug; 11(8):1282-1292. PubMed ID: 27156442
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract][Full Text] [Related]
17. Maxillary carcinosarcoma: Identification of a novel MET mutation in both carcinomatous and sarcomatous components through next generation sequencing.
Ando M; Saito Y; Morikawa T; Omura G; Kobayashi K; Akashi K; Yoshida M; Ebihara Y; Fujimoto C; Fukayama M; Yamasoba T; Asakage T
Head Neck; 2015 Dec; 37(12):E179-85. PubMed ID: 25782598
[TBL] [Abstract][Full Text] [Related]
18. Carcinosarcoma and sarcomatoid carcinoma of the stomach: Two case reports.
Li Y; Cui L; Chen Y; Wang F
Medicine (Baltimore); 2021 Mar; 100(12):e24697. PubMed ID: 33761637
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinosarcoma with PTCH1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis.
Kiuru M; McDermott G; Coit DC; Berger MF; Busam KJ
Am J Surg Pathol; 2014 Jan; 38(1):138-42. PubMed ID: 24335643
[TBL] [Abstract][Full Text] [Related]
20. High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.
Fallet V; Saffroy R; Girard N; Mazieres J; Lantuejoul S; Vieira T; Rouquette I; Thivolet-Bejui F; Ung M; Poulot V; Schlick L; Moro-Sibilot D; Antoine M; Cadranel J; Lemoine A; Wislez M
Ann Oncol; 2015 Aug; 26(8):1748-53. PubMed ID: 25969368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
